Back to Search
Start Over
Clinical Outcomes in Pre-Hospital Activation and Direct Cardiac Catheterisation Laboratory Transfer of STEMI for Primary PCI.
- Source :
-
Heart, lung & circulation [Heart Lung Circ] 2022 Jul; Vol. 31 (7), pp. 974-984. Date of Electronic Publication: 2022 Feb 25. - Publication Year :
- 2022
-
Abstract
- Introduction: Pre-hospital activation and direct cardiac catheterisation laboratory (CCL) transfer of ST segment elevation myocardial infarction (STEMI) has previously been shown to improve door-to-balloon (DTB) times yet there is limited outcome data in the Australian context. We aimed to assess the impact of pre-hospital activation on STEMI performance measures and mortality.<br />Methods: Prospective cohort study of consecutive ambulance transported STEMI patients treated with primary percutaneous coronary intervention (PCI) patients over a 10-year period (1 January 2008-31 December 2017) at The Prince Charles Hospital, a large quaternary referral centre in Brisbane, Queensland Australia. Comparisons were performed between patients who underwent pre-hospital CCL activation and patients who did not. STEMI performance measures, 30-day and 1-year mortality were examined.<br />Results: Amongst 1,009 patients included (mean age: 62.8 yrs±12.6), pre-hospital activation increased over time (26.6% in 2008 to 75.0% in 2017, p<0.001). Median DTB time (35 mins vs 76 mins p<0.001) and percentage meeting targets (DTB<60 mins 92% vs 27%, p<0.001) improved significantly with pre-hospital activation. Pre-hospital activation was associated with significantly lower 30-day (1.0% vs 3.5%, p=0.007) and 1-year (1.2% vs 7.7%, p<0.001) mortality. After adjusting for confounders and mediators, we observed a strong total effect of pre-hospital activation on 1-year mortality (OR 5.3, 95%CI 2.2-12.4, p<0.001) compared to patients who did not have pre-hospital activation. False positive rates were 3.7% with pre-hospital activation.<br />Conclusion: In patients who underwent primary PCI for STEMI, pre-hospital activation and direct CCL transfer is associated with low false positive rates, significantly reduced time to reperfusion and lower 30-day and 1-year mortality.<br />Competing Interests: Ethics Approval/s This study was approved by the Human Research Ethics Committee of the Prince Charles Hospital (LNR/2018/QPCH/47412), the Australian Institute of Health and Welfare ethics committee (EO2020/2/1147) and the Queensland Ambulance Service.<br /> (Crown Copyright © 2022. Published by Elsevier B.V. All rights reserved.)
Details
- Language :
- English
- ISSN :
- 1444-2892
- Volume :
- 31
- Issue :
- 7
- Database :
- MEDLINE
- Journal :
- Heart, lung & circulation
- Publication Type :
- Academic Journal
- Accession number :
- 35227611
- Full Text :
- https://doi.org/10.1016/j.hlc.2022.01.008